Trials / Unknown
UnknownNCT05031858
Effect of Vojta Therapy on Covid-19 Respiratory Disease
Effect of Vojta Therapy in Respiratory Disease Caused by SARS-CoV-2. Randomized Controlled Pilot Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- NUMEN Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Vojta therapy is a physiotherapy intervention with scientific evidence in respiratory pathologies in children and proven in adults. In this pilot study with an RCT design, its effect in adult patients with respiratory pathology caused by the SARS-CoV-2 virus will be studied. The non-invasive and non-painful technique consists of applying tolerable pressure to specific areas of the patient's body. The objective is to activate, in a reflex way, the ventilatory physiology. It is compared with the conventional respiratory physiotherapy approach.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Respiratory physiotherapy | Respiratory physiotherapy |
Timeline
- Start date
- 2021-09-25
- Primary completion
- 2021-12-20
- Completion
- 2022-04-15
- First posted
- 2021-09-02
- Last updated
- 2021-09-02
Source: ClinicalTrials.gov record NCT05031858. Inclusion in this directory is not an endorsement.